Regulation & law · 08/10/2002Updated: 10/17/2026 · 1 min read

IPR Pharmaceuticals, Inc. Receives Approval to Expand Manufacturing Authority in Puerto Rico's Subzone 61G

IPR Pharmaceuticals, Inc. has received approval to expand its manufacturing authority within Subzone 61G in Carolina, Puerto Rico, allowing the company to increase its pharmaceutical production capabilities.